QPS Holdings, LLC is a global leader in bioanalysis, preclinical, and clinical research services, providing a comprehensive range of offerings in the pharmaceutical and biotechnology sectors. With over 25 years of experience, QPS specializes in drug development, including pharmacology, toxicology, DMPK, and bioanalysis services, as well as early and late-phase clinical trials. Their services cover various therapeutic areas such as oncology, dermatology, endocrinology, and more. QPS emphasizes agility, flexibility, speed, and quality, offering custom-built research solutions and maintaining strong regulatory and ethics committee relationships to support their clients' drug development needs.